Downregulation of beta-microglobulin to diminish T-lymphocyte lysis of non-syngeneic cell sources of engineered heart tissue constructs.

Biomedical Materials
Zaruhi KarabekianNarine Sarvazyan

Abstract

The presence of non-autologous major histocompatibility complex class I (MHC-I) molecules on the surface of the grafted cells is one of the main reasons for their rejection in non-syngeneic hosts. We present a straightforward strategy to decrease the presence of MHC-I by shRNA inhibition of beta-2-microglobulin (B2M), a conservative light chain of MHC-I, on the surface of two main cell types that are used to engineer heart tissue constructs. Engineered heart tissue constructs can be generated by combining mouse WT19 fibroblasts and mouse embryonic stem cell-derived cardiac myocytes (mESC-CM). WT19 fibroblasts were stably transduced with an anti-B2M shRNA, which yielded a cell line with dramatically reduced B2M expression levels (16 ± 11% of mock treated control cell line). Interferon gamma treatment increased the levels of B2M expression by >3-fold in both control and transduced fibroblasts; yet, B2M expression levels still remained very low in the transduced cells. When compared with their unmodified counterparts, transduced fibroblasts caused 5.7-fold lesser activation of cognate T-cells. B2M depletion in mESC-CM was achieved by 72 h transduction with anti-B2M shRNA lentiviral particles. Transduced mESC-CM exhibited regular b...Continue Reading

References

Mar 1, 1994·International Immunology·S Sanderson, N Shastri
Jan 1, 1997·Annual Review of Immunology·U BoehmJ C Howard
Nov 5, 1997·Nature Biotechnology·R ZuffereyD Trono
Feb 26, 2000·Annual Review of Genetics·H TangF Wong-Staal
Jul 19, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Ara ArutunyanNarine Sarvazyan
Aug 16, 2002·Transplant Immunology·Thomas EschenhagenWolfram-Hubertus Zimmermann
Aug 30, 2005·The American Journal of Pathology·Michael A LaflammeCharles E Murry
Mar 8, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Constança FigueiredoRainer Blasczyk
Apr 4, 2006·Nature Medicine·Wolfram-Hubertus ZimmermannThomas Eschenhagen
Jan 9, 2007·Transfusion·Constança FigueiredoAxel Seltsam
Feb 8, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jeannette NussbaumCharles E Murry
Sep 14, 2007·Circulation·Yalin YildirimWolfram-Hubertus Zimmermann
Nov 6, 2007·Journal of the American College of Cardiology·Oren CaspiLior Gepstein
Mar 26, 2008·BioTechniques·Karina BakuntsNarine Sarvazyan
Feb 14, 2009·Circulation Research·Jianhua ZhangTimothy J Kamp
Apr 24, 2010·Transfusion·Constança FigueiredoAxel Seltsam
Nov 19, 2010·Stem Cell Reviews and Reports·Zaruhi KarabekianNarine Sarvazyan
May 17, 2011·Nature·Tongbiao ZhaoYang Xu
Oct 15, 2011·Cells, Tissues, Organs·Donald O FreytesGordana Vunjak-Novakovic
Sep 11, 2012·Cellular and Molecular Life Sciences : CMLS·Limor Zwi-Dantsis, Lior Gepstein
Feb 2, 2013·Circulation Research·Patricia E de AlmeidaJoseph C Wu
May 1, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Laura RiolobosDavid W Russell
Dec 19, 2013·BioMed Research International·Constança FigueiredoRainer Blasczyk
Aug 2, 2014·Journal of the American College of Cardiology·Veronica Sanchez-FreireJoseph C Wu

❮ Previous
Next ❯

Citations

Jul 29, 2015·Tissue Engineering. Part a·Zaruhi KarabekianNarine Sarvazyan
Jun 13, 2015·Biomedical Materials·Milica Radisic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.